SYNOVIAL SARCOMA

SYNOVIAL SARCOMA was reported 95 times

SYNOVIAL SARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 9 0.0001
1 Penem Antibacterial [EPC] 3 0.0001
2 Antisense Oligonucleotide [EPC] 1 0.0001
3 Alkylating Drug [EPC] 15 0.0001
4 Integrin Receptor Antagonist [EPC] 5 0.0001
5 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
6 Platinum-based Drug [EPC] 11 0.0000
7 Rifamycin Antibacterial [EPC] 1 0.0000
8 Microtubule Inhibitor [EPC] 4 0.0000
9 Interferon beta [EPC] 4 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 9 0.0000
11 Antirheumatic Agent [EPC] 2 0.0000
12 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
13 Parathyroid Hormone Analog [EPC] 2 0.0000
14 Aromatase Inhibitor [EPC] 2 0.0000
15 Amide Local Anesthetic [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 6 0.0000
17 Estrogen [EPC] 2 0.0000
18 Acetylcholine Release Inhibitor [EPC] 1 0.0000
19 Interleukin-23 Antagonist [EPC] 1 0.0000
20 Fluoroquinolone Antibacterial [EPC] 1 0.0000
21 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
22 Leukocyte Growth Factor [EPC] 1 0.0000
23 Calcium [EPC] 1 0.0000
24 Vitamin D [EPC] 2 0.0000
25 Janus Kinase Inhibitor [EPC] 1 0.0000
26 Vitamin B12 [EPC] 2 0.0000
27 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
28 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 3 0.0000
30 RANK Ligand Inhibitor [EPC] 1 0.0000
31 Thiazide Diuretic [EPC] 1 0.0000
32 Vitamin C [EPC] 2 0.0000
33 Retinoid [EPC] 1 0.0000
34 Thalidomide Analog [EPC] 2 0.0000
35 Osmotic Laxative [EPC] 1 0.0000
36 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
39 Benzodiazepine [EPC] 1 0.0000
40 Corticosteroid [EPC] 1 0.0000